Wilmington/Munich — Bayer has agreed to spend more than $12bn to resolve thousands of US lawsuits and deal with future claims, taking its biggest step so far in resolving headaches the German chemical giant inherited in its acquisition of Monsanto.
Munich — Bayer’s Werner Baumann has a return engagement with shareholders after an unprecedented rebuke in 2019. Though an avalanche of Roundup litigation has grown, the CEO appears to be on firmer footing this time around.
Munich — Bayer has acknowledged for the first time that lawsuits related to the controversial weed killer Roundup could force it to sell assets, issue new equity, or borrow money at unfavourable terms.
Munich — Bayer chair Werner Wenning is leaving the German drugs and chemicals company before his term expires, capping a half-century of dealmaking that culminated in the contentious Monsanto acquisition and a blizzard of lawsuits over its Roundup weedkiller.
Frankfurt — Germany’s Bayer has agreed with plaintiffs to postpone its next two US lawsuits over the alleged cancer-causing effects of its glyphosate-based weed killers to allow more time for talks on a settlement.
Where have all the bees and butterflies gone? It sounds like a whimsical folk song but environmental activists say it’s deadly serious and that pesticides are killing these and other insects which play a vital role in both nature and crop farming.